The last 20 actions on file set price targets from $8.00 to $12.00, averaging $10.50.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 29 Sep 2026 | Northland Securities | BUY | $12.00 |
| 25 Sep 2026 | Craig-Hallum | BUY | – |
| 25 Sep 2026 | J.P. Morgan | BUY | $8.00 |
| 18 Sep 2026 | Northland Securities | BUY | $12.00 |
| 14 Sep 2026 | Northland Securities | BUY | $12.00 |
| 27 Aug 2026 | StoneX | BUY | $10.00 |
| 11 Aug 2026 | Stifel | HOLD | $8.50 |
| 10 Aug 2026 | Northland Securities | BUY | $12.00 |
| 7 Aug 2026 | Wells Fargo | HOLD | $8.00 |
| 7 Aug 2026 | Truist Financial | BUY | – |
| 7 Aug 2026 | Freedom Capital Markets | BUY | $10.00 |
| 7 Aug 2026 | Stifel | HOLD | $8.50 |
| 7 Aug 2026 | Needham | BUY | $12.00 |
| 7 Aug 2026 | Goldman Sachs | BUY | $10.50 |
| 7 Aug 2026 | Roth MKM | BUY | $12.00 |
| 7 Aug 2026 | Oppenheimer | BUY | $12.00 |
| 6 Aug 2026 | Guggenheim | BUY | $12.00 |
| 6 Aug 2026 | Roth MKM | BUY | $10.00 |
| 31 Jul 2026 | Oppenheimer | BUY | $10.00 |
| 27 Jul 2026 | Goldman Sachs | BUY | $9.50 |
No comments yet — be the first to weigh in on GENI.